Skip to content

Clinical effect of intercostobrachial nerve block in distal humeral surgery

Clinical effect of intercostobrachial nerve block in distal humeral surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000040898
Enrollment
Unknown
Registered
2020-12-14
Start date
2021-02-01
Completion date
Unknown
Last updated
2021-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fracture of distal humerus

Interventions

PM Group:Ultrasound guided brachial plexus block and intercostobrachial nerve block (performed between pectoralis minor and serratus anterior)
AR Group:Ultrasound guided brachial plexus block and intercostobrachial nerve block (in axillary region)
S Group:Ultrasound guided brachial plexus block and local anesthetics (injected subcutaneously at the root of the upper arm near the armpit, along the medial side of the upper arm to the lower edge of
PV Group:Ultrasound guided brachial plexus block and T2 paravertebral block

Sponsors

Department of Anesthesiology, Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) Consent to join the study and obtain informed consent; 2) Aged 18-75 years(inclusive); 3) American Society of anesthesiologists (ASA) grade I-II; 4) Patients diagnosed with distal humeral fractures undergoing selective open reduction; 5) The surgical approach was the posterolateral median incision of elbow joint, and the operation position was lateral or prone position.

Exclusion criteria

Exclusion criteria: 1) The patient refused regional anesthesia; 2) More than 5 years history of diabetes; 3) History of drug allergy; 4) Clinical cognitive impairment (mini mental state score < 24); 5) Chronic pain symptoms; 6) Clinical and subclinical nerve injury; 7) Patients with history of malignant tumor, radiotherapy and pathological fracture; 8) Puncture site infection; 9) History of pregnancy and peripheral neuropathic pain.

Design outcomes

Primary

MeasureTime frame
Range of sensory block;Sensory score;The patient complained of pain;Intraoperative opioid use;

Secondary

MeasureTime frame
VAS score 48 hours after operation;Conversion rate to general anesthesia;

Countries

China

Contacts

Public ContactChen Moxi

Department of Anesthesiology, Shanghai Sixth People's Hospital

chanmx@163.com+86 18930174386

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026